Patrick B. Kyle
Professor
Department:
SOM-Pathology
Email:
pkyle@umc.edu
Work Phone:
(601) 984-2352
Biography
Dr. Kyle is a Professor of Pathology and the Director of the Clinical Chemistry, Special Chemistry, Serology and Toxicology laboratories at the University of Mississippi Medical Center. He is board certified as a Clinical Chemist (ABCC), Toxicological Chemist (ABCC), and Forensic Toxicology Specialist (ABFT). In addition to providing oversight to the laboratory, he also teaches medical students, dental students and Pathology residents. He is an international speaker, has authored over 50 peer-reviewed journal articles and book chapters, and serves as a reviewer for several scientific journals. His research interests include pharmaceutical toxicity, analytical method development, laboratory management and emerging biomarkers of disease.
Education
| University of Mississippi, PhD, Pharmacology/Toxicology | 2006 |
| Mississippi College, BS, Biology | 1991 |
Specialty Certification Licensure
| Certification, Forensic Toxicology Specialist, American Board of Forensic Toxicology | 10/2011 - Present |
| Certification, Clinical Chemistry, American Board of Clinical Chemistry | 07/2012 - Present |
| Certification, Toxicological Chemistry, American Board of Clinical Chemistry | 07/2011 - Present |
| Certification, Clinical Chemist, National Registry of Certified Chemists | 02/2009 - Present |
| Certification, Toxicological Chemist, National Registry of Certified Chemists | 11/2006 - Present |
Current Positions
| Associate Professor, School of Medicine, Department of Pathology | 07/2014 - Present |
| Director of Clinical Chemistry, Special Chemistry, and Toxicology, Department of Pathology | 2012 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Pathology | 03/2009 - 06/2014 |
| Interim Laboratory Director, Mississippi Public Health Laboratory | 06/2008 - 05/2009 |
| Instructor, University of Mississippi Medical Center, School of Medicine, Department of Pathology | 03/2006 - 03/2009 |
| Associate Director of Clinical Chemistry and Toxicology, University of Mississippi Medical Center, Department of Pathology | 03/2006 - 12/2011 |
| School of Medicine, Department of Pathology |
Sponsored Program Funding
| Intramural, Interdisciplinary Quality Improvement Measures in Treating Cystic Fibrosis Patients, UMMC - Faculty Scholarship Exchange Award | 08/2013 - 07/2014 |
| Extramural, Role of Eicosanoids in the Progression of Renal Disease in African Americans, NIH - COBRE | 07/2013 - 06/2016 |
| Extramural, Methods Comparison for Systematic Toxicology Analysis by GC/MS, Thermo Scientific Inc. | 03/2013 - 02/2014 |
| Extramural, Measureable Cardiotoxicity resulting from Therapeutic Micafungin Infusion, Astellas Pharma U.S., Inc. | 07/2011 - 06/2012 |
| Extramural, Jackson Heart Study - Subcontract for Laboratory Services, NHLBI | 08/2010 - 12/2012 |
| Extramural, Analgesic Technique on Pain and Biomarkers, National Institute of Health | 01/2010 - 12/2011 |
| Extramural, Center for Research Excellence in Psychiatric Neuroscience, National Institutes of Health / National Center for Research Resources | 07/2007 - 06/2012 |
Publications
Statewide Newsletter | |
| Kyle PB. Mississippi Toxicology Bulletin Mississippi Toxicology Bulletin. 2018. 3:1. | 2018 |
| Kyle PB, Kaur J. Mississippi Toxicology Bulletin. Mississippi Toxicology Bulletin. 2017. 2:2. | 2017 |
| Spencer L, Walley R, Kyle PB. Mississippi Toxicology Bulletin. Mississippi Toxicology Bulletin. 2017. 2:1. | 2017 |
| Kyle PB. Mississippi Toxicology Newsletter. Mississippi Toxicology Newsletter. 2016. 1:1 | 2016 |
Journal Article | |
| Morris R, Spencer SK, Barnes A, Bowles T, Kyle PB, Wallace K. Attenuation of oxidative stress and hypertension in an animal model of HELLP syndrome. European Journal of Pharmacology. 2018. 834:136-141. | 2018 |
| Spencer S, Shaffery J, Kyle PB, Wallace K. Hypertension, anxiety and blood brain barrier permeability are increased in post-partum severe preeclampsia/HELLP syndrome rats. Hypertension. 2018 | 2018 |
| Kasper AM,Ridpath AD, Gerona RR, Cox R, Galli R, Kyle PB, Parker C, Arnold JK, Chatham-Stephens K, Morrison MA, Olayinka O, Preacely N, Kieszak SM, Martin C, Schier JG, Wolkin A, Byers P, Dobbs T. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015). Clinical Toxicology. 2018. 10:1-9. | 2018 |
| Bean C, Spencer SK, Bowles T, Kyle PB, Williams JM, Gibbens J, Wallace K. Inhibition of T-cell activation attenuates hypertension, TNFα, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance. American Journal of Reproductive Immunology. 2016. 76(4):272-9. | 2016 |
| Morris R, SPencer L, Kyle PB, Williams JM, Harris A, Owens MY, Wallace K. Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1. Reproductive Sciences. 2016. 23(1):42-50. | 2016 |
| Kasper AM, Ridpath AD, Arnold JK, Chatham-Stephens K, Morrison M, Olayinka O, Parker C, Galli R, Cox R, Preacely N, Anderson J, Kyle PB, Gerona R, Martin C, Schier J, Wolkin A, Dobbs T. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015. Morbidity Mortality Weekly Report. 2015. 64(39):1121-2. | 2015 |
| Jia Z, Johnson AC, Wang X, Guo Z, Driesbach AW, Lewin J, Kyle PB, Garrett MR. Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat. PLOS One. 2015. 10(7):e0132553. | 2015 |
| Rajkowska G, Mahajan G, Sathyanesan M, Iyo AH, Moulana M, Kyle PB, Woolverton WL, Miguel-Hidalgo JJ, Stockmeier CA, and Newton SS. Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorder. Journal of Psychiatric Research. 2015;65:53-62. | 2015 |
| Wang X, Johnson A, Williams J, White T, Chade A, Zhang J, Liu R, Roman R, Lee J, Kyle P, Solberg W, and Garrett M. Nephron deficiency and predisposition to renal injury in a novel one-kidney genetic model. Journal of the American Society of Nephrology. 2014. In Press. | 2014 |
| Driesbach AW, Smith SV, Kyle PB, Ramaiah M, Amenuke M, Garrett MR, Lirette ST, Griswold ME, and Roman RJ. Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease. Prostaglandins and Other Lipid Mediators. 2014. In Press. | 2014 |
| Westbrook L, Johnson AC, Regner KR, Williams JM, Mattson DL, Kyle PB, Henegar JR, and Garrett MR. Genetic susceptibility and loss of Nr4a1 enhances macrophage-mediated renal injury in CKD. Journal of the American Society of Nephrology. 2014. In Press. | 2014 |
| Wallace K, Morris R, Kyle PB, Cornelius D, Darby M, Scott J, Moseley J, Chatman K, and LaMarca B. Hypertension, Inflammation and T Lymphocytes are Increased in a Rat Model of HELLP Syndrome. Hypertension in Pregnancy. | 2014 |
| Stover KR, Farley JM, Kyle PB, Cleary J. Cardiac Toxicity of Some Echinocandin Antifungals. Expert Opinion on Drug Safety. 2014. 13(1):5-14. | 2014 |
| Slaughter TN, Paige A, Spires D, Kojima N, Kyle PB, Garrett MR, Roman RJ, Williams JM. Characterization of the Development of REnal Injury in Type-1 Diabetic Dahl Salt-sensitive Rats. Am J Physiol Regul Integr Comp Physiol. 2013; In Press | 2013 |
| Cleary JD, Stover KR, Farley J, Daley W, Kyle PB, Hosler J. Cardiac toxicity of azole antifungals. Pharmacology and Pharmacy. 2013; 4:362-368. | 2013 |
| Regner KR, Harmon AC, Williams JM, Stelloh C, Johnson AC, Kyle PB, Lerch-Gabbl A, White SM, Garrett MR. Increased Susceptibility ot Kidney Injury by transfer of Genomic Segment from SHR onto Dahl S genetic background. Physiol Genomics. 2012;44:629-637. | 2012 |
| Kyle PB, Brown KB, Bailey AP, Stevenson JL. Reactivity of commercial Benzodiazepine Immunoassays to Phenazepam. J Anal Toxicol. 2012; 36:207-209. | 2012 |
| Kyle PB, Lawrence TJ. Aberrant Lamellar Body Counts noted on teh Beckman Coulter Unicel DxH 800. Clin chem Lab Med. 2012;50:1631-1633. | 2012 |
| Kyle PB, Smith SV, Baker RC, Kramer RE. Mass Spectrometric detection of CYP450 adducts following oxidative desulfuration of Methyl Parathion. J Appl Toxicol. 2013;33:644-651. | 2012 |
| Kyle PB, Iverson RB, Gajagowni RG, Spencer L. Illicit Bath Salts: not for Bathing. J Miss State Med Assoc. 2011; 52:375-377. | 2011 |
| Bogdan R, Fitzgibbon H, Woolverton WL, Bethea CL, Iyo AH, Stockmeier CA, Kyle PB, Austin MC. 5-HTTLPR Genotype and Gender, but not Chronic Fluoxetine Administration, are associated with Cortical TREK1 Protein Expression in Rhesus Macaques. Neurosci Lett. 2011; 503:83-86. | 2011 |
| Cox RD, Kyle PB, Brackin B, Snazelle T, Surkin J. Blood Lead Levels in Mississippi Children. J Miss State Med Assoc. 2010; 51:206-210. | 2010 |
| Szeczyk B, Albert PR, Rogaeva A, Fitzgibbon H, May WL, Rajkowska G, Miguel-Hidalgo JJ, Stockmeier CA, Woolverton WL, Kyle PB, Wang Z, Austin MC. Decreased expression of Freud-1/CC2D1A, aa transcriptional repressor of the 5-HT1A receptor in the prefrontal cortex of subjects with major depression. Int J Neuropsychopharmacol. 2010; 13:1089-1101. | 2010 |
| Kyle PB. Beware of Carryover in Modern Chemistry Analyzers. Clinical Chemistry and Laboratory Medicine. 2010. 48(4):519-521. | 2010 |
| Feyissa AM, Woolverton WL, Miguel-Hidalgo JJ, Wang Z, Kyle PB, Hasler G, Stockmeier CA, Iyo AH, Karolewicz B. Elevated level of Metabotropic Glutamate Receptor 2/3 in teh Prefrontal Cortex in Major Depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34:279-283. | 2010 |
| Kyle PB, Daley WP. Domestic Abuse of the European Rave Drug Prolintane. J Anal toxicol. 2007; 31:415-418. | 2007 |
| Adcock KG, Kyle PB, Deaton JS, Olivier JH, Hogan SM. Pharmacokinetics of Intranasal and Intratracheal Pentoxifylline in Rabbits. Pharmacotherapy. 2007; 27:200-206. | 2007 |
| Glisson JK, Wood RL, Kyle PB, Cleary JD. Bioavailability of Promethazine in a topical Pluronic Lecithin Organogel: A Pilot Study. Int J Pharm Compd. 2005; 9:242-246. | 2005 |
| Kyle PB, Adcock KG, Kramer RE, Baker RC. Use of Liquid Chromatography-Tandem Mass Spectrometry for the analysis of Pentoxifylline and Lisofylline in Plasma. Biomed Chromatogr. 2005; 19:231-236. | 2005 |
| Zhu MY, Kyle PB, Hume AS, Ordway GA. The Persistent Membrane Retention of Desipramine causes lasting Inhibition of Norepinephrine. Neurochem Res. 2004; 29:419-427. | 2004 |
| Kyle PB, Spencer JL, Purser CM, Hume AS. Drugs Detected in Suspected Pediatric Ingestions: a three-year review. J Miss State Med Assoc. 2004; 45:35-40. | 2004 |
| Kyle PB, Spencer JL, Purser CM, Eddleman KC, Hume AS. Suspected Pediatric Ingestions: Effectiveness of Immunoassay Screens vs. Gas Chromatography/Mass Spectroscopy in the Detection of Drugs and Chemicals. J Toxicol Clin Toxicol. 2003; 41:919-925. | 2003 |
Abstracts | |
| Kyle PB, Kaur J. Evaluation of new specimen validity markers. Journal of Analytical Toxicology. Annual Meeting Abstracts. 2018 | 2018 |
| Gibbens JD, SPencer SK, Bowles T, Kyle PB, Morris R, Wallace K. Anti-angiogenic imbalance during pregnancy: is the Fas/FasL system a contributor? American Journal of Obstetrics and Gynecology. 2017. 216(1):S546. | 2017 |
| Bean C, Spencer SK, Bowles T, Kyle PB, Evidence that perinatal hypertension and inflammation leads to chronic inflammation, hypertension and neurological changes in an animal model of HELLP syndrome. 37th Annual Meeting of the Society for Maternal Fetal Medicine: The Pregnancy Meeting. January 23-28, 2017. | 2017 |
| Kasper AM, Gerona R, Ridpath A, Galli R, Arnold J, Cox R, Anderson J, Kyle P, Martin C, Shier J, Wolkin A, Dobbs T. Severe illness associated with a novel synthetic cannabinoid - Mississippi, April 2015. 65th Annual Epidemic Intelligence Service Conference. May 2-5, 2016. page 98. | 2016 |
| Kyle PB, Chekuri S. Laboratory utilization of HbA1c, PSA and BMP in an academic medical center. Clinical Chemistry. 2015. 61(10):s170. 2015 Annual Meeting Abstracts. American Assocaition for Clinical Chemistry. | 2015 |
| Kyle PB and Brown KB. Using Technological Advances to Improve Laboratory Turn around Times. Clinical Chemistry. 2014 Annual Meeting Abstracts. S201, #B171. | 2014 |
| Kyle PB, Bhaijee F, Magee L, Booth D. A highly sensitive quadrupole GC-MS for quantitative and qualitative toxicology. Mass Spectrometry: Applications to the Clinical Lab. 2014. | 2014 |
| Kyle PB, Bhaijee F, Magee L, and Booth D. A highly sensitive quadrupole GC-MS for quantitative and qualitative toxicology. Journal of Analytical Toxicology. 2013;37(8):xx. | 2014 |
| Kyle PB, Bhaijee F, Magee L, Booth D. A Quadrupole GC/MS with Dual-Role Toxicology Capability. Journal of Analytical Toxicology | 2013 |
| Johnson AC, Guo Z, Kyle PB, and Garrett MR. Use of Congenic Strains, Comparative Genome Hybridization, and Whole Genomic Sequencing to Dissect the Genetic Basis of Chronic Kidney Disease in teh Dahl S. Hypertension. 2013;62:A517. | 2013 |
| Wallace K, Darby M, Kyle PB, Morris R, Moseley J, Frazier K, Scott J, and LaMarca B. Hypertension in a rat model of HELLP syndrome is associated with increased TNF-alfa, IL-6, and CD4 T cell activation. FASEB Journal, 2013;27:1115.7 | 2013 |
| Slaughter T, Paige A, Fan F, Kyle P, Geurts AM, Jacob HJ, Roman RJ, and Williams JM> Involvement of Matrix Metalloproteinase-2 During the Progression of Renal Disease in Diabetic Dahl Salt-Sensitive Rats. Hypertension. 2012; 60(3):A55. | 2012 |
| Dreisbach AW, Smith SV, Kyle PB, Ramaiah M, Amenuke M, Garrett MR, Lirette ST Griswold ME, and Roman RJ. Urinary CYP Eicosanoid Excretion Correlates with Glomerular Filtration Rate in African-Americans with Chronic Kidney Disease. Hypertension. 2012; 60(3):A348. | 2012 |
| Slaughter T, Paige A, Rucker C, Kyle P, Kojima N, Garrett MR, Roman RJ, and Williams JM. Temporal Characterization of the Development of Diabetic-Induced Renal Disease in Strains of Goto-kakizaki Rats. Hypertension. 2012; 60(3):A134. | 2012 |
| Wallace K, Darby M, Kyle P, Scott J, Moseley J, Brewer J, Owens MY, and LaMarca B. Hypertension in a Rat Model of HELLP Syndrome is Associated with T Helper 1 Type Immune Activation. Hypertension. 2012; 60:A176 | 2012 |
| Westbrook L, Regner KR, Johnson A, Lee J, Kyle PB, Mattson DL, and Garrett MR. Loss of Nr4a1 on a Hypertensive Genetic Background Promotes Immune-Mediacted Renal Injury. Hypertension. 2012; 60(3 Abstracts):A1. | 2012 |
| Kyle PB, Bhaijee F, and Booth DD. Clinical Toxicology Results after Supplementation of Commercial GC/MS Libraries. Clinical Chemistry. 2012; 58(9):A193. | 2012 |
| Williams JM, Slaughter T, Wells A, Rucker C, spires D, Kyle PB, and Roman RJ. Increased MMP-9 Activity During the Progression of Renal Injury in Type-2 Diabetic Nephropathy Rats. FASEB Journal. 2012; 26(supplement):687.4 | 2012 |
| Slaughter T, Spires D, Rucker C, WElls A, Kyle P, Roman RJ, and Williams JM. The Reduction of Renal Injury in Diabetic Dahl Salt-Sensitive Rats with Insulin is Associated with Decreased MMP Activity. FASEB Journal. 2012; 26:687.3 | 2012 |
| Rucker C, Spires D, Slaughter T, Wells A, Kyle PB, Roman R, and Williams J. Involvement of Matrix Metalloproteinases During the Progression of Renal Injury in Type-II diabetic Nephropathy Rats. Journal of the Mississippi Academy of Sciences. 2012; 57(1):109 | 2012 |
| Spires D, Slaughter T, Rucker C, Wells A, Kyle PB, roman RJ, and Williams JM. Controlling Plasma Glucose LEvels Reduces Renal Injury in Diabetic Dahl Salt-Sensitive Rats. Journal of the Mississippi Academy of Sciences. 2012; 57(1):109 | 2012 |
| Stover KR, Kyle PB, Farley J, and Cleary JD. Echinocandin Myocardial Toxicity. | 2011 |
| Kyle PB, Booth D, Magee L, and Spencer JL. Comparison of Six Extraction methods for Emergency Toxicology Screening. Clinical Chemistry. 2011;57(S10):A55 | 2011 |
| Wang J, Adeosun S, Jiao Y, Henry S, Hill R, Zheng B, Sun c, Hou X, Pani A, Kyle P, Bigler S, Farley S, Stockmeier C, Paul I, Brinton RD, Smeyne R. The Impact of a Neurogenic Agen, Allopregnanolone in Rodent Models of Alzheimer's and Parkinson's Disease. Alzheimer's & Dementia. 2011;7(4):s667. | 2011 |
| Austin MC, Goswami DB, Fitzgibbon H, Woolverton WL, Stockmeier CA, Kyle PB, Bethea CL, and Barth J. Microarray Gene Expression Profiling of Prefrontal Cortex in Chronic Fluoxetine-Treated Rhesus Monkeys: Sex Differences. Biological Psychiatry. 2011; 69:56s. | 2011 |
| Spires D, Wells A, Zhang J, Kyle PB, Roman RJ, and Williams JM. Progression of Diabetic-Induced Renal Injury in Diabetic Dahl Salt-Sensitive Rats Journal of the Mississippi Academy of Sciences. 2011; 69:56s. | 2011 |
| Brown J, Wells A, Kyle PB, Roman RJ, and Williams JM. Effects of a High Salt Diet on the Progression of Renal Injury in Diabetic Dahl Salt-Sensitive Rats. Journal of the Mississippi Academy of Science. 2011. 56(1):141. | 2011 |
| Legutko B, Abel K, Migual-Hidalgo J, Wang Z, Kyle P, Woolverton W, Maciag D, Stockmeier C, and Rajkowska G. Fluoxetine Treatment Does Not Alter Density or Size of CNPase-Immunoreactive Oligodendrocytes in Prefrontal White Matter in Rhesus Monkeys Biol Psychiatry. 2010. 67(9):54s. Accepted for Publication | 2010 |
| Feyissa AM, Chandran A, Legutko B, Woolverton WL, Wang Z, Austin M, Miguel-Hidalgo JJ, Rajkowska G, Kyle P, Stockmeier CA, and Karolewicz B. Reduced Level of Metabotropic Glutamate Receptor 5 (mGlu5R) Protein in the Prefrontal Cortex in Major Depressive Disorder. Soc Neuroscience. 2009. 34:156.4. | 2009 |
| Adcock KG, Kyle PB, Deaton JS, and Olivier J. Pentoxifylline Pharmacokinetics Following Two Novel Delivery Techniques American College of Clinical Pharmacy. 2004. 24(10):1453 abstract 219. | 2004 |
Book Chapter | |
| Kyle PB. Toxicology: GC-MS. Mass Spectrometry for the Clinical Laboratory. Elsevier, Academy Press. San Diego, CA. Eds. Nair H. and Clarke W. 2017. ISBN: 978-0-12-800871-3. | 2017 |
Book | |
| Kyle PB, Fuller DC, Garg U, Hammett-Stabler CA, Hoess E, Johnson-Davis K, Kapur BM, Langman LJ, LeGatt DF, Loughmiller D, Pesce A, Sadek W, Smith MP, Watson ID, Wolf CE, Wu A, Zhang YV. Toxicology and Drug Testing in the Medical Laboratory. CLSI. Toxicology and Drug Testing in the Medical Laboratory. 3rd ed. CLSI Guideline C52 (ISBN 1-56238-808-8 [Print]; ISBN 1-56238-809-6 [Electronic). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2017. | 2017 |
Presentations
| National and International Invited Seminars/Lectures, Accurate Results in Clinical Laboratories: Addressing Pre-Analytical, Analytical, and Post Analytical Errors, American Society for Clinical Pathology, Chicago, IL | 09/2024 |
| State/Local Invited Seminars/Lectures, Toxicology: Mississippi has a Problem You can help Solve through Testing, Pathology for Primary Care Specialists, Ridgeland, MS | 03/2024 |
| National and International Invited Seminars/Lectures, Illicit Opioids: What you Should Know, National Opioid Awareness Day, Abbott Diagnostics, Webinar - Worldwide | 09/2023 |
| National and International Invited Seminars/Lectures, Navigating Laboratory Issues in the Preanalytical, Analytical and Postanalytical Phases, American Association for Clinical Chemistry, Anaheim, CA | 07/2023 |
| National and International Invited Seminars/Lectures, Biotin Interference in Laboratory Assays, International Federation for Clinical Chemistry, Rome, Italy | 05/2023 |
| State/Local Invited Seminars/Lectures, Toxicology: Options in Testing and Interpretation of Results, Pathology for Primary Care Specialists, Flowood, MS | 05/2023 |
| National and International Invited Seminars/Lectures, Strategies for Improving Laboratory Turnaround Times, American Association for Clinical Chemistry, Chicago, IL | 07/2022 |
| State/Local Invited Seminars/Lectures, Pharmacokinetics of THC and effects on Driving, Juvenile Drug Court, Web Conference - Hattiesburg, MS | 07/2022 |
| National and International Invited Seminars/Lectures, Beautiful skin but erroneous test results: The AACC Academy Guidance Document on Biotin Interference in Laboratory Immunoassays, American Association for Clinical Chemistry, Anaheim, California | 08/2019 |
| National and International Invited Seminars/Lectures, Biotin Interference in Laboratory Immunoassays, Canadian Society of Clinical Chemists, Saint John, Canada | 06/2019 |
| National and International Invited Seminars/Lectures, Evaluating New Specimen Validity Markers., Society of Forensic Toxicology, Annual Meeting, Minneapolis, MN | 10/2018 |
| State/Local Invited Seminars/Lectures, Toxicology: Drug Trends and Ways People Avoid Detection., UMMC Advance Practice Providers, Annual Regional Meeting, Jackson, MS | 10/2018 |
| Regional Invited Seminars/Lectures, Addressing the Opioid Epidemic: Understanding the Problem and How to Fix It., American Society of Clinical Laboratory Sciences, Annual Bi State (MS & LA) Meeting, Biloxi, MS | 04/2018 |
| State/Local Invited Seminars/Lectures, Toxicology Testing in Pain Management., Physician Prescriber Series, University of MS Medical Center, Jackson, MS | 03/2018 |
| National and International Invited Seminars/Lectures, Applications of High Resolution Mass Spectrometry in Forensic Toxicology., Society of Forensic Toxicology, Annual Meeting, Dallas, TX | 10/2016 |
| National and International Invited Seminars/Lectures, The recently Revised CLSI C52 - Toxicology and Drug Testing in the Clinical Laboratory., American Association for Clinical Chemistry, Annual Meeting, Philadelphia, PA | 08/2016 |
| National and International Invited Seminars/Lectures, Tactics for Reducing Laboratory Turn-Around Times., American Association for Clinical Chemistry, Annual Meeting, Philadelphia, PA | 08/2016 |
| National and International Invited Seminars/Lectures, Laboratory Utilization of HbA1c, PSA and BMP in an Academic Medical Center., Americal Association for Clinical Chemstry, Annual Meeting, Atlanta, GA | 07/2015 |
| Regional Invited Seminars/Lectures, Immunoassay Interactions and Interferences., Americal Association for Clinical Chemistry - Southeast Section, Orange Beach, AL | 05/2015 |
| Psychiatry Grand Rounds, Toxicology Testing: Differentiating False-Positive and False-Negative Results., UMMC Department of Psychiatry, University of Mississippi Medical Center | 06/2014 |
| Regional Invited Seminars/Lectures, Toxicology in the Modern World: From synthetic opiods to bath salts., American Society for Clinical Laboratory Science, Annual Bi-State Meeting, Biloxi, MS | 05/2014 |
| Regional Invited Seminars/Lectures, Tactics for Reducing Laboratory Turn Around Times., Annual Tri-State American Society for Clinical Laboratory Science Region 3 meeting, Biloxi, MS | 11/2013 |
| National and International Invited Seminars/Lectures, Issues in Providing Regional Toxicology Services., American Association for Clinical Chemistry - Annual Meeting, Houston, TX, USA | 07/2013 |
| Regional Invited Seminars/Lectures, Current Methods for Fetal Lung Maturity Testing., Annual Tri-State American Society for Clinical Laboratory Science Region 3 meeting, Tunica, MS | 04/2012 |
| Scientific Presentations, Assay Harmonization - Why do we need it, Where are we going?, University of North Carolina, Chapel Hill, North Carolina | 05/2011 |
Honors, Awards, and Recognition
| Clinical Pathology Attending of the Year, University of Mississippi Medical Center, Pathology | 2024 |
| Excellence in Research Award, University of MS Medical Center | 2020 |
| Clinical Pathology Attending of the Year, University of Mississippi Medical Center, Pathology | 2019 |
| Leadership and Service Recognition Award, Clinical and Laboratory Standards Institute | 2018 |
| 2015 Outstanding Speaker Award, American Association for Clinical Chemistry | 2015 |
| 2013 Outstanding Speaker Award, American Association for Clinical Chemistry | 2014 |
| Clinical Chemist Recognition Award, American Association for Clinical Chemistry | 2011 |
| Young Investigator Scholarship, GenNext Technologies Inc. | 2006 |
Professional Membership and Service
| Association for Diagnostics and Laboratory Medicine, Member | 2024 - Present |
| Association for Diagnostics and Laboratory Medicine, Fellow | 2024 - Present |
| American Board of Clinical Chemistry, Board of Directors of a Company | 2014 - 2019 |
| American Association for Clinical Chemistry, Fellow | 2013 - 2023 |
| Clinical and Laboratory Standards Institute, Member | 2013 - Present |
| Society of Forensic Toxicologists, Member | 2007 - Present |
| American Association for Clinical Chemistry, Member | 2006 - 2023 |
| American Association for Mass Spectrometry, Member | 2006 - Present |
Committee Service
| Annual Meeting Organizing Committee, Association for Diagnostics and Laboratory Medicine, Member | 2023 - 2024 |
| Document Development Committee, Association for Diagnostics and Laboratory Medicine, Co-Chair | 2022 - Present |
| UMMC COVID-19 Biosurveillance Task Force, Member | 2021 - 2023 |
| Annual Meeting Organizing Committee, American Association for Clinical Chemistry, Member | 2019 - 2020 |
| Toxicology Exam Committee, American Board of Clinical Chemistry, Chair | 2019 - 2019 |
| Document Development Committee on Biotin Interference, AACC Academy Council, American Assocation for Clinical Chemistry, Chair | 2018 - 2020 |
| AACC Academy Council, American Association for Clinical Chemistry, Director | 2018 - 2021 |
| Clinical Chemistry Expert Panel, Clinical and Laboratory Standards Institute, Member | 2018 - 2019 |
| UMMC Opioid Task Force, Member | 2018 - Present |
| Lab Test Utilization Committee, Member | 2017 - Present |
| Chemistry/Toxicology Expert Advisory Panel, The Joint Commission, Member | 2016 - 2016 |
| Abstract Review Committee, National Academy for Clinical Biochemistry, Member | 2015 - 2015 |
| Annual Meeting Program Committee, American Association for Clinical Chemistry, Southeast Section, Member | 2015 - 2015 |
| Toxicology Exam Subcommittee, American Board of Clinical Chemistry, Member | 2014 - 2019 |
| Exam Credentialing Committee, American Board of Clinical Chemistry, Member | 2014 - 2019 |
| Board of Directors, American Board of Clinical Chemistry, Member | 2014 - 2019 |
| C52 Document Revision Committee, Clinical and Laboratory Standards Institute, Chair | 2014 - 2016 |
| American Association for Clinical Chemistry - Southeast Section, Chair | 2014 - 2014 |
| Annual Meeting Abstract Review Committee, American Association for Clinical Chemistry, Member | 2014 - 2016 |
| Annual Meeting Program Committee, American Association for Clinical Chemistry - Southeast Section, Chair | 2014 - 2014 |
| Laboratory Steering Committee for Ebola Preparation, Member | 2014 - 2015 |
| Interdisciplinary Quality Improvement Committee for treatment of cystic fibrosis patients with aminoglycoside antibiotics, Member | 2014 - 2015 |
| Clinical Chemistry Committee, Clinical and Laboratory Standards Institute, Member | 2013 - 2016 |
| American Association for Clinical Chemistry TDM/Toxicology Division, Board of Directors | 2013 - 2015 |
| Medical Student Research Program Commitee, Member | 2012 - 2015 |
| Jackson Heart Study - Laboratory Subcommittee, Member | 2011 - Present |
| MEDICAL CENTER-FACULTY SENATE, Chair | 2010 - 2011 |
| MEDICAL CENTER-SACS LEADERSHIP, Member | 2010 - 2011 |
| Medical Center - Quality Enhancement Plan Development Committee, Member | 2010 - 2014 |
| MEDICAL CENTER-FACULTY DEVELOPMENT, Member | 2010 - 2011 |
| UMMC Laboratory Safety Committee, Chair | 2010 - Present |
| Graduate Alumni Association - Board of Directors, Member | 2009 - 2013 |
| THE UNIVERSITY HOSPITALS AND CLINICS-PHARMACY AND THERAPEUTICS, Member | 2008 - Present |
| MEDICAL CENTER-RADIATION/LASER SAFETY, Member | 2008 - Present |
| MEDICAL CENTER-FACULTY SENATE, Member | 2008 - 2014 |
| Center for Psychiatric Neuroscience, Animal Core Supervisor | 2007 - 2010 |
Community Service
| BSA Troop 178, Boy Scouts of America, Scoutmaster | 03/2014 - 05/2022 |
Other Service
| Practical Laboratory Medicine | 2017 - 12/2017 |
| Drug and Alcohol Dependence | 2016 - 12/2016 |
| American Journal of Forensic Science | 2016 - 12/2016 |
| Annual School of Medicine Research Day, Judge | 2013 - 12/2015 |
| Journal of Applied Toxicology | 2013 - 12/2013 |
| Journal of Obstetrics and Gynaecology Research | 2013 - 2013 |
| Clinica Chimica Acta | 2012 - Present |
| Clinical Chemistry and Laboratory Medicine | 2012 - Present |
| Journal of Clinical Toxicology | 2012 - 12/2012 |
| Laboratory Inspection, College of American Pathologists, Laboratory Inspector | 07/2011 - 07/2011 |
| Clinical Biochemistry | 2011 - 12/2011 |
| Journal of Analytical Toxicology | 2011 - 12/2019 |
| Laboratory Inspection, College of American Pathologists, Laboratory Inspector | 05/2009 - 05/2009 |
| Annual SHRP Research Day, Judge | 2009 - 12/2012 |
| Pediatrics International | 2009 - 12/2009 |
| Laboratory Inspection, College of American Pathologists | 08/2007 - 08/2007 |
| American Journal of Clinical Pathology | 2007 - 12/2007 |
| Laboratory Inspection, College of American Pathologists, Laboratory Inspection | 10/2006 - 10/2006 |
| Rapid Communications in Mass Spectrometry | 2006 - 12/2006 |
| Chemical Terrorism Registry, Society of Toxicology, Member | 2004 - 12/2008 |
Teaching Experience
| 637, Dentistry, Course, Lecturer, Dental Pathology | Summer 2018 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2018 |
| 637, Dentistry, Course, Lecturer, Dental Pathology | Summer 2017 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2017 |
| 637, Dentistry, Course, Lecturer, Dental Pathology | Fall 2016 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2016 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2015 |
| 637, Dentistry, Course, Lecturer, Dental Pathology | Fall 2015 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2014 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2013 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2012 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2011 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2010 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2009 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2008 |
| 703, Graduate, Course, Lecturer, Orientation to Pharmacological Research | Fall 2008 - 2010 |
| 621, Medicine, Course, Lecturer, Medical Pathology | Spring 2007 - 2011 |
Directed Student Learning
| Preceptor | 2008 - 2008 |
Residency Training
| Anatomic/Clinical Pathology Residency, Training Faculty | 2006 - Present |